참고문헌
- Birmaher B, Brent DA, Benson RS. Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 1998;37:1234-1238. https://doi.org/10.1097/00004583-199811000-00029
- Dopheide JA. Recognizing and treating depression in children and adolescents. Am J Health Syst Pharm 2006;63:233-243. https://doi.org/10.2146/ajhp050264
- Fergusson DM, Horwood LJ, Ridder EM, Beautrais AL. Subthreshold depression in adolescence and mental health outcomes in adulthood. Arch Gen Psychiatry 2005;62:66-72. https://doi.org/10.1001/archpsyc.62.1.66
- Kaufman J, Martin A, King RA, Charney D. Are child-, adolescent-, and adult-onset depression one and the same disorder? Biol Psychiatry 2001;49:980-1001. https://doi.org/10.1016/S0006-3223(01)01127-1
- Lewinsohn PM, Pettit JW, Joiner TE Jr, Seeley JR. The symptomatic expression of major depressive disorder in adolescents and young adults. J Abnorm Psychol 2003;112:244-252. https://doi.org/10.1037/0021-843X.112.2.244
- Luby JL, Mrakotsky C, Heffelfinger A, Brown K, Spitznagel E. Characteristics of depressed preschoolers with and without anhedonia: evidence for a melancholic depressive subtype in young children. Am J Psychiatry 2004;161:1998-2004. https://doi.org/10.1176/appi.ajp.161.11.1998
- Kovacs M, Obrosky DS, Gatsonis C, Richards C. First-episode major depressive and dysthymic disorder in childhood: clinical and sociodemographic factors in recovery. J Am Acad Child Adolesc Psychiatry 1997;36:777-784. https://doi.org/10.1097/00004583-199706000-00014
- McCauley E, Myers K, Mitchell J, Calderon R, Schloredt K, Treder R. Depression in young people: initial presentation and clinical course. J Am Acad Child Adolesc Psychiatry 1993;32:714-722. https://doi.org/10.1097/00004583-199307000-00003
- Weissman MM, Wolk S, Goldstein RB, Moreau D, Adams P, Greenwald S, et al. Depressed adolescents grown up. JAMA 1999;281:1707-1713. https://doi.org/10.1001/jama.281.18.1707
- Garnock-Jones KP, McCormack PL. Escitalopram: a review of its use in the management of major depressive disorder in adults. CNS Drugs 2010;24:769-796. https://doi.org/10.2165/11204760-000000000-00000
- US FDA. Forest Pharmaceuticals I. [Cited 2013 Feb 8] Available from URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021323s2 8s29,021365s18s19lbl.pdf?utm_campaign=Google2& utm_source=fdaSearch&utm_medium=website&utm_term=lexapro&utm_content=7.
- Rao N. The clinical pharmacokinetics of escitalopram. Clin Pharmacokinet 2007;46:281-290. https://doi.org/10.2165/00003088-200746040-00002
- US FDA. Forest Pharmaceuticals I. [Cited 2013 Feb 8] Available from URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/018936s075s077lbl.pdf?utm_campaign=Google2&utm_source=fdaSearch&utm_ medium=website&utm_term=prozac, pediatric&utm_content=9.
- US FDA. Forest Pharmaceuticals I. [Cited 2013 Feb 8] Available from URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/ 2009/021323s030s031,021365s021s022lbl.pdf.
- Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S. Escitalopram in the treatment of adolescent depression: a randomized placebocontrolled multisite trial. J Am Acad Child Adolesc Psychiatry 2009;48:721-729. https://doi.org/10.1097/CHI.0b013e3181a2b304
- Wagner KD, Jonas J, Findling RL, Ventura D, Saikali K. A doubleblind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 2006;45:280-288. https://doi.org/10.1097/01.chi.0000192250.38400.9e
- Findling R, Bose A, Aquino D, Korotzer A, Tourkodimitris S. Sixmonth double-blind escitalopram treatment of depressed adolescents. Poster Presentation at American Academy of Child & Adolescent Psychiatry Annual Meeting; 2008 Oct 28. Chicago, USA:Elsevier;2008.
- Carandang C, Jabbal R, Macbride A, Elbe D. A review of escitalopram and citalopram in child and adolescent depression. J Can Acad Child Adolesc Psychiatry 2011;20:315-324.
- Stamouli SS, Yfantis A, Lamboussis E, Liakouras A, Lagari V, Tzanakaki M, et al. Escitalopram in clinical practice in Greece: treatment response and tolerability in depressed patients. Expert Opin Pharmacother 2009;10:937-945. https://doi.org/10.1517/14656560902810375
- Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006;63:332-339. https://doi.org/10.1001/archpsyc.63.3.332
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision. Washington DC: American Psychiatric Press;2000.
- Tao R, Emslie GJ, Mayes TL, Nakonezny PA, Kennard BD. Symptom improvement and residual symptoms during acute antidepressant treatment in pediatric major depressive disorder. J Child Adolesc Psychopharmacol 2010;20:423-430. https://doi.org/10.1089/cap.2009.0116
- Cheung AH, Emslie GJ, Mayes TL. Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry 2005;46:735-754. https://doi.org/10.1111/j.1469-7610.2005.01467.x
- Isolan L, Pheula G, Salum GA Jr, Oswald S, Rohde LA, Manfro GG. An open-label trial of escitalopram in children and adolescents with social anxiety disorder. J Child Adolesc Psychopharmacol 2007;17:751-760. https://doi.org/10.1089/cap.2007.0007
- Schirman S, Kronenberg S, Apter A, Brent D, Melhem N, Pick N, et al. Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study. J Neural Transm 2010;117:139-145. https://doi.org/10.1007/s00702-009-0330-x
피인용 문헌
- Psychometric Properties and Factor Structures of the Korean Version of Children's Depression Rating Scale-Revised 2017, https://doi.org/10.1089/cap.2016.0183